Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Energy · Chemicals & Allied Products

Allkem Limited to acquire Livent Corp.

Announced Aug 2, 2023 · Closed Jan 4, 2024

Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed

Transaction

Acquirer
Allkem Limited
Target
Livent Corp.
Buyer type
Strategic
Offer price per share
—
Enterprise value
—
Status
Closed Jan 4, 2024

Deal protections

Break fee (target pays)
$64.6M
Reverse fee (buyer pays)
$64.6M
Go-shop
—
Financing
—

Advisors

To the acquirer
Not disclosed
To the target
Gordon Dyal

Sector context · Energy

Comparable deals
34 in the prior 24 months
Premium
Sector median 24.6%
EV / Adj. EBITDA
Sector median 8.7x
Break fee
Sector median 2.9%

Timeline

  1. AnnouncedAug 2, 2023
  2. Proxy filedNov 20, 2023
  3. Definitive proxyNov 20, 2023
  4. Shareholder voteDec 19, 2023
  5. ClosedJan 4, 2024
Sources
  • 8-K · Aug 2, 2023
  • 8-K · Dec 27, 2023

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.